A gene called BCAT1 is more active in many cancers, including one type of glioma
Original title: A pan-cancer analysis of the oncogenic role of branched-chain aminotransferase 1 (BCAT1) in human tumors.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was a computer study of tumor data that already existed, and the authors say more work is needed.
The short version
Researchers looked at data from past cancer studies and found that a gene called BCAT1 is often more active in tumors, and that this is linked to shorter survival.
What was studied. Researchers used two large public databases of tumor samples. They looked at how active the BCAT1 gene was across 33 types of cancer. They also looked at survival, gene changes, and immune cells in the tumors.
What they found. BCAT1 was more active in most cancers than in normal tissue. In several cancers, higher BCAT1 activity went along with a shorter time living and a shorter time before the cancer came back. This included lower grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, a type of brain tumor, and adrenocortical carcinoma. Tumors with more BCAT1 also tended to have fewer CD8+ T cells, which are immune cells that fight cancer.
What this means, and what it doesn't
What it could mean: This points to BCAT1 as something worth studying more in brain tumors. It might one day help doctors understand how a tumor is likely to behave. It might also become a target for future drugs.
What it doesn't mean: This is not a treatment, and it is not a cure. The study only looked at data already collected from tumor samples. It did not test any drug in people. The authors say the link they found does not prove that BCAT1 causes the worse outcomes, and that more lab work and testing is needed. Nothing here changes the care you get today.
Source: PubMed, July 31, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.